ID   20.3
AC   CVCL_J620
SY   TAb 250; Tab 250
DR   CLO; CLO_0001180
DR   ATCC; CRL-2655
DR   ATCC; HB-10646
DR   Wikidata; Q54582947
RX   Patent=US6884418;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10646.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
RX   Patent=US6884418;
RA   Shawver L.K., Brandis J.W., Mann E., Hancock M.E.C., Mischak R.P.,
RA   Monahan J.J.;
RT   "Use of ligand-mimicking agents and anti-neoplastic drugs in cancer
RT   therapy.";
RL   Patent number US6884418, 26-Apr-2005.
//